Durmus, A. Et Al. 2005. Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.9 , 1001-1004.

Durmus, A., Dogan, E., Erkoc, R., Sayarlioglu, H., Topal, C., & Dilek, I., (2005). Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.9, 1001-1004.

Durmus, A Et Al. "Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.9, 1001-1004, 2005

Durmus, A Et Al. "Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.9, pp.1001-1004, 2005

Durmus, A. Et Al. (2005) . "Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.9, pp.1001-1004.

@article{article, author={A Durmus Et Al. }, title={Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2005, pages={1001-1004} }